| Dr Anthony Cultrara, MD | |
|
1020 N Kings Hwy, Suite 201, Cherry Hill, NJ 08034-1906 | |
| (856) 667-1575 | |
| (856) 946-1747 |
| Full Name | Dr Anthony Cultrara |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 26 Years |
| Location | 1020 N Kings Hwy, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083619860 | NPI | - | NPPES |
| 3321541 | Other | NJ | AETNA |
| 0072857000 | Other | NJ | AMERIHEALTH |
| 134233377 | Other | NJ | HORIZON |
| 2682508 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 25MA07615000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Otolaryngology Head And Neck Associates, Llc | 9739162637 | 38 |
News Archive
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.
Parents who may be concerned by a scare over the side effects of the whooping cough vaccine will be reassured by a new study involving thousands of children. The Department of Health advice that babies should be vaccinated against whooping cough (pertussis) at the age of two, three and four months has been questioned by some scientists who have suggested a link with asthma and allergies.
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response rate to existing drugs.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
› Verified 5 days ago
| Entity Name | Regional Otolaryngology Head And Neck Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679528426 PECOS PAC ID: 9739162637 Enrollment ID: O20040611000013 |
News Archive
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.
Parents who may be concerned by a scare over the side effects of the whooping cough vaccine will be reassured by a new study involving thousands of children. The Department of Health advice that babies should be vaccinated against whooping cough (pertussis) at the age of two, three and four months has been questioned by some scientists who have suggested a link with asthma and allergies.
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response rate to existing drugs.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Cultrara, MD Po Box 95000-5585, Philadelphia, PA 19195-5585 Ph: (856) 667-1575 | Dr Anthony Cultrara, MD 1020 N Kings Hwy, Suite 201, Cherry Hill, NJ 08034-1906 Ph: (856) 667-1575 |
News Archive
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.
Parents who may be concerned by a scare over the side effects of the whooping cough vaccine will be reassured by a new study involving thousands of children. The Department of Health advice that babies should be vaccinated against whooping cough (pertussis) at the age of two, three and four months has been questioned by some scientists who have suggested a link with asthma and allergies.
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response rate to existing drugs.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
› Verified 5 days ago
Howard Bresalier, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1020 Kings Hwy N Ste 201, Cherry Hill, NJ 08034 Phone: 856-602-4000 Fax: 856-946-1747 | |
Dr. Nils G Herdelin Jr., MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 400 Kings Hwy S, Cherry Hill, NJ 08034 Phone: 856-428-5488 Fax: 856-428-6716 | |
Dr. Brendan M. O'brien, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1020 Kings Hwy N Ste 201, Cherry Hill, NJ 08034 Phone: 856-502-4000 Fax: 856-946-1747 | |
Dr. Anthony Charles Corrado, D.O. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite C, Cherry Hill, NJ 08003 Phone: 856-344-5906 | |
Ashmit Gupta, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1020 Kings Hwy N Ste 201, Cherry Hill, NJ 08034 Phone: 856-602-4000 Fax: 856-210-2849 | |
Dr. Herbert James Deutsch, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1101 Kings Hwy N, Suite 306, Cherry Hill, NJ 08034 Phone: 856-667-3700 Fax: 856-667-5192 |